Docetaxel-loaded-lipid-based-nanosuspensions (DTX-LNS): Preparation, pharmacokinetics, tissue distribution and antitumor activity

International Journal of Pharmaceutics

Volumn 413, Issue 1-2, 2011, Pages 194-201

  Wang, Lili ^a   Liu, Zhihong ^a   Liu, Donghua ^a   Liu, Chunxi ^a   Juan, Zhang ^a   Zhang, Na ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Antitumor activity; Docetaxel; Lipid based nanosuspensions (DTX LNS)

Indexed keywords

DOCETAXEL; DUOPAFEI; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; FREEZE DRYING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIPID BASED NANOSUSPENSION; MACROPHAGE; MELANOMA; MOUSE; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SURVIVAL RATE; SUSPENSION; TISSUE DISTRIBUTION; TUMOR VOLUME; ZETA POTENTIAL;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; EXCIPIENTS; FEMALE; FORMAZANS; HUMANS; LECITHINS; LIPIDS; MELANOMA; MICE; NANOPARTICLES; NEOPLASMS; OVARIAN NEOPLASMS; PARTICLE SIZE; SUSPENSIONS; TAXOIDS; TETRAZOLIUM SALTS; TISSUE DISTRIBUTION;

EID: 79957971638     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.04.023     Document Type: Article

References (39)

1. S.S. Adkins, H.R. Hobbs, K. Benaissi, K.P. Johnston, M. Poliakoff, and N.R. Thomas Stable colloidal dispersions of a lipase-perfluoropolyether complex in liquid and supercritical carbon dioxide J. Phys. Chem. B 112 2008 4760 4769
2. A. Ain-Ai, and P.K. Gupta Effect of arginine hydrochloride and hydroxypropyl cellulose as stabilizers on the physical stability of high drug loading nanosuspensions of a poorly soluble compound Int. J. Pharm. 351 2008 282 288 (Pubitemid 351186858)
3. B.H. Bohm, and R.H. Muller Lab-scale production unit design for nanosuspensions of sparingly soluble cytotoxic drugs Pharm. Sci. Technol. Today 2 1999 336 339 (Pubitemid 29378538)
4. E. Campora, G. Colloca, R. Ratti, G. Addamo, Z. Coccorullo, A. Venturino, and D. Guarneri Docetaxel for metastatic breast cancer: two consecutive phase II trials Anticancer Res. 28 2008 3993 3995
5. C.Y. Chu, C.H. Yang, C.Y. Yang, G.H. Hsiao, and H.C. Chiu Fixed erythrodysaesthesia plaque due to intravenous injection of docetaxel Br. J. Dermatol. 142 2000 808 811
6. S.J. Clarke, and L.P. Rivory Clinical pharmacokinetics of docetaxel Clin. Pharmacokinet. 36 1999 99 114 (Pubitemid 29121684)
7. F. Danhier, N. Lecouturier, B. Vroman, C. Jerome, J. Marchand-Brynaert, O. Feron, and V. Preat Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation J. Control. Release 133 2009 11 17
8. F.V. Fossella, J.S. Lee, D.M. Shin, M. Calayag, M. Huber, R. Perez-Soler, W.K. Murphy, S. Lippman, S. Benner, and B. Glisson Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer J. Clin. Oncol. 13 1995 645 651
9. L. Gao, D. Zhang, M. Chen, C. Duan, W. Dai, L. Jia, and W. Zhao Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions Int. J. Pharm. 355 2008 321 327
10. P.Y. Grosse, F. Bressolle, and F. Pinguet In vitro modulation of doxorubicin and docetaxel antitumoral activity by methyl-beta-cyclodextrin Eur. J. Cancer 34 1998 168 174 (Pubitemid 28123396)
11. H.Y. Hwang, I.S. Kim, I.C. Kwon, and Y.H. Kim Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles J. Control. Release 128 2008 23 31
12. S.B. Kaye, M. Piccart, M. Aapro, P. Francis, and J. Kavanagh Phase II trials of docetaxel (Taxotere (R)) in advanced ovarian cancer - an updated overview Eur. J. Cancer 33 1997 2167 2170
13. C.M. Keck, and R.H. Muller Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation Eur. J. Pharm. Biopharm. 62 2006 3 16 (Pubitemid 41736019)
14. P. Kocbek, S. Baumgartner, and J. Kristl Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs Int. J. Pharm. 312 2006 179 186
15. X. Li, R. Li, X. Qian, Y. Ding, Y. Tu, R. Guo, Y. Hu, X. Jiang, W. Guo, and B. Liu Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate Eur. J. Pharm. Biopharm. 70 2008 726 734
16. X. Li, D. Wang, J. Zhang, and W. Pan Preparation and pharmacokinetics of docetaxel based on nanostructured lipid carriers J. Pharm. Pharmacol. 61 2009 1485 1492
17. Müller, R.H., et al., 2000. Solid-lipid(semi-solid) lipid particles and method of producing highly concentrated lipid particle dispersions, German.
18. K. Manjunath, and V. Venkateswarlu Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration J. Control. Release 107 2005 215 228 (Pubitemid 41319672)
19. T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65 1983 55 63 (Pubitemid 14203433)
20. R.H. Muller, M. Radtke, and S.A. Wissing Nanostructured lipid matrices for improved microencapsulation of drugs Int. J. Pharm. 242 2002 121 128
21. S. Naik, D. Patel, N. Surti, and A. Misra Preparation of PEGylated liposomes of docetaxel using supercritical fluid technology J. Supercrit. Fluids 54 2010 110 119
22. K.T. Oh, E.S. Lee, D. Kim, and Y.H. Bae l-Histidine-based pH-sensitive anticancer drug carrier micelle: reconstitution and brief evaluation of its systemic toxicity Int. J. Pharm. 358 2008 177 183
23. K. Peters, S. Leitzke, J.E. Diederichs, K. Borner, H. Hahn, R.H. Muller, and S. Ehlers Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection J. Antimicrob. Chemother. 45 2000 77 83 (Pubitemid 30060237)
24. B.E. Rabinow Nanosuspensions in drug delivery Nat. Rev. Drug Discov. 3 2004 785 796 (Pubitemid 39242830)
25. J.H. Rebecca, and K.C. Johnson The effect of particle size distribution on dissolution rate and oral absorption Int. J. Pharm. 51 1989 9 17 (Pubitemid 19087827)
26. M. Senthilkumar, P. Mishra, and N.K. Jain Long circulating PEGylated poly (d, l-lactide-co-glycolide) nanoparticulate delivery of Docetaxel to solid tumors J. Drug Target 16 2008 424 435 (Pubitemid 351935740)
27. B. Sjostrom, B. Bergenstahl, and B. Kronberg A method for the preparation of submicron particles of sparingly water-soluble drugs by precipitation in oil-in-water emulsions. II: influence of the emulsifier, the solvent, and the drug substance J. Pharm. Sci. 82 1993 584 589 (Pubitemid 23216001)
28. W. Sun, N. Zhang, A. Li, W. Zou, and W. Xu Preparation and evaluation of N(3)-O-toluyl-fluorouracil-loaded liposomes Int. J. Pharm. 353 2008 243 250
29. O. Tredan, C.M. Galmarini, K. Patel, and I.F. Tannock Drug resistance and the solid tumor microenvironment J. Natl. Cancer Inst. 99 2007 1441 1454
30. M. Trotta, M. Gallarate, F. Pattarino, and S. Morel Emulsions containing partially water-miscible solvents for the preparation of drug nanosuspensions J. Control. Release 76 2001 119 128 (Pubitemid 32786890)
31. Wang, L.L., et al., 2010. A method of producing lyophilized Docetaxel nanocrystalline, China.
32. H.L. Wong, R. Bendayan, A.M. Rauth, Y. Li, and X.Y. Wu Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles Adv. Drug Deliv. Rev. 59 2007 491 504 (Pubitemid 47259227)
33. Z. Xu, L. Chen, W. Gu, Y. Gao, L. Lin, Z. Zhang, Y. Xi, and Y. Li The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma Biomaterials 30 2009 226 232
34. N. Yanasarn, B.R. Sloat, and Z.R. Cui Nanoparticles engineered from lecithin-in-water emulsions as a potential delivery system for docetaxel Int. J. Pharm. 379 2009 174 180
35. G.X. Zhai, J. Wu, B. Yu, C.Y. Guo, X.G. Yang, and R.J. Lee A transferrin receptor-targeted liposomal formulation for docetaxel J. Nanosci. Nanotechnol. 10 2010 5129 5136
36. J. Zhang, Z. Qian, and Y. Gu In vivo anti-tumor efficacy of docetaxel-loaded thermally responsive nanohydrogel Nanotechnology 20 2009 325102
37. L. Zhang, Y. Hu, X. Jiang, C. Yang, W. Lu, and Y.H. Yang Camptothecin derivative-loaded poly (caprolactone-co-lactide)-b-PEG-b-poly (caprolactone-co-lactide) nanoparticles and their biodistribution in mice J. Control. Release 96 2004 135 148 (Pubitemid 38438496)
38. L. Zhang, M. Yang, Q. Wang, Y. Li, R. Guo, X. Jiang, C. Yang, and B. Liu 10-Hydroxycamptothecin loaded nanoparticles: preparation and antitumor activity in mice J. Control. Release 119 2007 153 162 (Pubitemid 46754506)
39. D. Zheng, X. Li, H. Xu, X. Lu, Y. Hu, and W. Fan Study on docetaxel-loaded nanoparticles with high antitumor efficacy against malignant melanoma Acta Biochim. Biophys. Sin. (Shanghai) 41 2009 578 587